A carregar...
Targeted Therapy in Chronic Lymphocytic Leukemia
Despite a prevailing view that advances in cancer therapy will come through selective targeting of enzymes encoded by mutated oncogenes responsible for the neoplastic phenotype, recent advances in the treatment of patients with chronic lymphocytic leukemia (cLL) have instead exploited knowledge of i...
Na minha lista:
| Publicado no: | Cancer J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039327/ https://ncbi.nlm.nih.gov/pubmed/31764118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000416 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|